NCT00006124View on ClinicalTrials.gov

Celecoxib in Treating Patients With Bladder Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

March 31, 2006

Study Completion Date

April 30, 2008

Conditions
Recurrent Bladder Cancer
Interventions
DRUG

celecoxib

Given orally

DRUG

placebo

Given orally

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006124 - Celecoxib in Treating Patients With Bladder Cancer | Biotech Hunter | Biotech Hunter